A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)

NCT00732875 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

BIOLOGICAL: Infliximab + methotrexate (MTX)

Sponsor

Merck Sharp & Dohme LLC